Search Results

SANT-1 100 mg  | 100.00%

TargetMol

SANT-1 directly binds to Smoothened (Smo) receptor (Kd: 1.2 nM) and inhibits Smo agonist effects (IC50: 20 nM).

More Information Supplier Page

NSC 228155 50 mg  | 99.84%

TargetMol

NSC 228155 is an activator of EGFR, binding to the sEGFR dimerization domain II and modulate EGFR tyrosine phosphorylation.

More Information Supplier Page

NSC 228155 25 mg  | 99.84%

TargetMol

NSC 228155 is an activator of EGFR, binding to the sEGFR dimerization domain II and modulate EGFR tyrosine phosphorylation.

More Information Supplier Page

Glabridin 100 mg  | 98.01%

TargetMol

Glabridin may serve as an anti-inflammatory agent in diabetes-related vascular dysfunction, through regulating the synthesis and activity of iNOS under high-glucose levels; may possess a therapeutic effect on metabolic disorders( such as diabetes and hyperglycemia), by modulating glucose metabolism through AMPK in skeletal muscle cells. Glabridin may have potential as a chemopreventive agent against liver […]

More Information Supplier Page

NSC 228155 5 mg  | 99.84%

TargetMol

NSC 228155 is an activator of EGFR, binding to the sEGFR dimerization domain II and modulate EGFR tyrosine phosphorylation.

More Information Supplier Page

NSC 228155 100 mg  | 99.84%

TargetMol

NSC 228155 is an activator of EGFR, binding to the sEGFR dimerization domain II and modulate EGFR tyrosine phosphorylation.

More Information Supplier Page

RGFP966 5 mg  | 99.77%

TargetMol

RGFP966 is an HDAC3 inhibitor (IC50: 0.08 μM) and does not affect other HDACs at concentrations up to 15 μM.

More Information Supplier Page

RGFP966 10 mg  | 99.77%

TargetMol

RGFP966 is an HDAC3 inhibitor (IC50: 0.08 μM) and does not affect other HDACs at concentrations up to 15 μM.

More Information Supplier Page